Consolidated Statement of Changes in Shareholders' Deficit - USD ($)	Common Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 7,230	$ 8,276	$ 2,638,311	$ (4,705,230)	$ (2,051,413)
Balance, shares at Dec. 31, 2017	72,302,937
Sale of common stock	$ 988		2,450,180		2,451,168
Sale of common stock, shares	9,875,228
Fair value of warrants allocated to proceeds of common stock			181,788		181,788
Fair value of shares issued with convertible notes payable	$ 4		5,593		5,597
Fair value of shares issued with convertible notes payable, shares	35,000
Fair value of warrants issued to extend convertible notes payable			229,900		229,900
Fair value of warrants issued to retire convertible notes payable			143,014		143,014
Conversion of convertible notes payable to common stock	$ 38		42,173		42,211
Conversion of convertible notes payable to common stock, shares	384,839
Derivative liabilities transferred to additional paid-in capital			2,846,921		2,846,921
Fair value of warrants issued for professional services			296,447		296,447
Consultant fees payable with common shares and warrants	$ 28	17,869	31,659		49,556
Consultant fees payable with common shares and warrants, shares	277,147
Fair value of warrants issued to extend related party notes payable			337,467		337,467
Shares and options issued pursuant to employee equity incentive plan	$ 40	(8)	102,598		102,630
Shares and options issued pursuant to employee equity incentive plan, shares	403,750
Sale of common stock initially allocated to derivative financial instruments			(1,774,298)		(1,774,298)
Exercise of stock warrants	$ 200		(200)
Exercise of stock warrants, shares	2,000,001
Repurchase and retirement of treasury shares	$ (10)			(4,990)	(5,000)
Repurchase and retirement of treasury shares, shares	(100,000)
Net loss				(5,790,835)	(5,790,835)
Balance at Dec. 31, 2018	$ 8,518	26,137	7,531,553	(10,501,055)	(2,934,847)
Balance, Shares at Dec. 31, 2018	85,178,902
Acquisition of Hughes Center for Functional Medicine	$ 397		999,603		1,000,000
Acquisition of Hughes Center for Functional Medicine, shares	3,968,254
Sale of common stock	$ 832	59,000	1,444,504		1,504,336
Sale of common stock, shares	8,313,992
Fair value of warrants allocated to proceeds of common stock			154,650		154,650
Shares issued with convertible notes payable	$ 14		28,303		28,317
Shares issued with convertible notes payable, shares	140,500
Fair value of warrants allocated to proceeds of convertible notes payable			225,323		225,323
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable			1,046,399		1,046,399
Conversion of convertible notes payable to common stock	$ 633		1,218,922		1,219,555
Conversion of convertible notes payable to common stock, shares	6,332,893
Fair value of warrants issued for professional services			54,257		54,257
Consultant fees payable with common shares and warrants	$ 56	67,240	108,026		175,322
Consultant fees payable with common shares and warrants, shares	560,000
Shares and options issued pursuant to employee equity incentive plan	$ 35	7,161	206,336		213,532
Shares and options issued pursuant to employee equity incentive plan, shares	349,063
Exercise of stock options	$ 11		(11)
Exercise of stock options, shares	113,141
Exercise of stock warrants	$ 494		(219)		275
Exercise of stock warrants, shares	4,937,745
Repurchase of treasury stock			(1,200)		(1,200)
Net loss				(5,528,599)	(5,528,599)
Balance at Dec. 31, 2019	$ 10,990	$ 159,538	$ 13,016,446	$ (16,029,654)	$ (2,842,680)
Balance, Shares at Dec. 31, 2019	109,894,490